Xtant Medical Holdings, Inc. (XTNT) - Form 8-K Summary
Business Context and Reporting Period
Xtant Medical Holdings, Inc., a Delaware corporation, filed this Current Report on Form 8-K on November 12, 2024. The filing announces the Company's financial results for the three and nine months ended September 30, 2024. The full details of these results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) for the actual figures. The Company utilizes non-GAAP adjusted EBITDA as a supplemental measure to evaluate core operational performance.
Material Changes and Non-GAAP Adjustments
While specific period-over-period financial changes are not detailed in this text, the Company outlines specific items excluded from its non-GAAP adjusted EBITDA to facilitate comparability:
- Separation related expenses: Excluded as they do not reflect ongoing operating results.
- Legal settlements: Excluded to assess core profitability.
- Non-cash compensation: Excluded due to reliance on unpredictable market valuations.
- Acquisition-related expenses and fair value adjustments: Excluded as they are not normal, recurring cash operating expenses.
- Gain on bargain purchase: Excluded as it is not reflective of ongoing operations.
- Unrealized foreign currency translation gain or loss: Excluded to focus on core business performance.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, outlook statements, or a detailed risk assessment within the text provided. Management commentary is limited to the rationale for using non-GAAP measures, stating that adjusted EBITDA aids in budgeting, resource allocation, and internal comparisons by factoring out charges not related to regular business.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures for Q3 and YTD 2024.
- Verify the reconciliation of Net Loss to Non-GAAP Adjusted EBITDA to understand the magnitude of excluded items.
- Confirm the Company's current liquidity position and debt levels, as these are not stated in the 8-K text.
- Assess the impact of the excluded "separation related expenses" and "legal settlements" on future cash flow.